These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 31813787)

  • 1. Implementation of non-communicable disease policies: a geopolitical analysis of 151 countries.
    Allen LN; Nicholson BD; Yeung BYT; Goiana-da-Silva F
    Lancet Glob Health; 2020 Jan; 8(1):e50-e58. PubMed ID: 31813787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implementation of non-communicable disease policies from 2015 to 2020: a geopolitical analysis of 194 countries.
    Allen LN; Wigley S; Holmer H
    Lancet Glob Health; 2021 Nov; 9(11):e1528-e1538. PubMed ID: 34678197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-communicable disease policy implementation from 2014 to 2021: a repeated cross-sectional analysis of global policy data for 194 countries.
    Allen LN; Wigley S; Holmer H; Barlow P
    Lancet Glob Health; 2023 Apr; 11(4):e525-e533. PubMed ID: 36925173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-communicable disease prevention policy process in five African countries.
    Juma PA; Mohamed SF; Matanje Mwagomba BL; Ndinda C; Mapa-Tassou C; Oluwasanu M; Oladepo O; Abiona O; Nkhata MJ; Wisdom JP; Mbanya JC
    BMC Public Health; 2018 Aug; 18(Suppl 1):961. PubMed ID: 30168393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in premature avertable mortality from non-communicable diseases for 195 countries and territories, 1990-2017: a population-based study.
    Martinez R; Lloyd-Sherlock P; Soliz P; Ebrahim S; Vega E; Ordunez P; McKee M
    Lancet Glob Health; 2020 Apr; 8(4):e511-e523. PubMed ID: 32199120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing the association between Corporate Financial Influence and implementation of policies to tackle commercial determinants of non-communicable diseases: A cross-sectional analysis of 172 countries.
    Allen LN; Wigley S; Holmer H
    Soc Sci Med; 2022 Mar; 297():114825. PubMed ID: 35228150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-sectoral action in non-communicable disease prevention policy development in five African countries.
    Juma PA; Mapa-Tassou C; Mohamed SF; Matanje Mwagomba BL; Ndinda C; Oluwasanu M; Mbanya JC; Nkhata MJ; Asiki G; Kyobutungi C
    BMC Public Health; 2018 Aug; 18(Suppl 1):953. PubMed ID: 30168391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncommunicable Disease Prevention and Control in Mongolia: A Policy Analysis.
    Chimeddamba O; Peeters A; Walls HL; Joyce C
    BMC Public Health; 2015 Jul; 15():660. PubMed ID: 26169789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barriers and Opportunities for WHO "Best Buys" Non-communicable Disease Policy Adoption and Implementation From a Political Economy Perspective: A Complexity Systematic Review.
    Loffreda G; Arakelyan S; Bou-Orm I; Holmer H; Allen LN; Witter S; Ager A; Diaconu K
    Int J Health Policy Manag; 2024; 13():7989. PubMed ID: 38618832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tracing Africa's progress towards implementing the Non-Communicable Diseases Global action plan 2013-2020: a synthesis of WHO country profile reports.
    Nyaaba GN; Stronks K; de-Graft Aikins A; Kengne AP; Agyemang C
    BMC Public Health; 2017 Apr; 17(1):297. PubMed ID: 28381252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An analysis of policy and funding priorities of global actors regarding noncommunicable disease in low- and middle-income countries.
    Jailobaeva K; Falconer J; Loffreda G; Arakelyan S; Witter S; Ager A
    Global Health; 2021 Jun; 17(1):68. PubMed ID: 34187499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4.
    NCD Countdown 2030 collaborators
    Lancet; 2018 Sep; 392(10152):1072-1088. PubMed ID: 30264707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of non-communicable diseases policies in post-apartheid South Africa.
    Ndinda C; Ndhlovu TP; Juma P; Asiki G; Kyobutungi C
    BMC Public Health; 2018 Aug; 18(Suppl 1):956. PubMed ID: 30168397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dynamic of non-communicable disease control policy in Indonesia.
    Christiani Y; Dugdale P; Tavener M; Byles JE
    Aust Health Rev; 2017 May; 41(2):207-213. PubMed ID: 27209156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bangladesh policy on prevention and control of non-communicable diseases: a policy analysis.
    Biswas T; Pervin S; Tanim MIA; Niessen L; Islam A
    BMC Public Health; 2017 Jun; 17(1):582. PubMed ID: 28629430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline status of policy and legislation actions to address non communicable diseases crisis in the Pacific.
    Win Tin ST; Kubuabola I; Ravuvu A; Snowdon W; Durand AM; Vivili P; Passmore E
    BMC Public Health; 2020 May; 20(1):660. PubMed ID: 32398159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation factors of non-communicable disease policies and programmes for children and youth in low-income and middle-income countries: a systematic review.
    Nguyen GT; Gauvreau C; Mansuri N; Wight L; Wong B; Neposlan J; Petricca K; Denburg A
    BMJ Paediatr Open; 2024 Jun; 8(1):. PubMed ID: 38830723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-communicable disease care and physical activity promotion in India: analysis of recent policies, guidelines and workplans.
    Mohanty S; Venkatarao E; Yasobant S
    Fam Med Community Health; 2020; 8(2):e000206. PubMed ID: 32518613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Profile of Non-Communicable Disease (NCD) research in the Middle East and North Africa (MENA) region: Analyzing the NCD burden, research outputs and international research collaboration.
    Aggarwal A; Patel P; Lewison G; Ekzayez A; Coutts A; Fouad FM; Shamieh O; Giacaman R; Kutluk T; Khalek RA; Lawler M; Boyle P; Sarfati D; Sullivan R
    PLoS One; 2020; 15(4):e0232077. PubMed ID: 32339197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment and prioritization of the WHO "best buys" and other recommended interventions for the prevention and control of non-communicable diseases in Iran.
    Bakhtiari A; Takian A; Majdzadeh R; Haghdoost AA
    BMC Public Health; 2020 Mar; 20(1):333. PubMed ID: 32171267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.